CBD, the non-psychoactive compound found in cannabis, hemp and hops, has been capturing media attention in recent times.
There is talk of the medicinal benefits of CBD, as it helps with the treatment of all conditions, from anxiety to inflammation; about its incorporation into everything from lubricants to coffee; about its incipient global popularity...
On the other hand, THC, the psychoactive compound in cannabis that makes people feel "high" or "high" is often overlooked (and sometimes even despised) when it comes to marijuana's medicinal potential.
Associated Content material: Shrooms vs. Acid
However, a study on the matter was conducted by Jacob Miguel Vigil, assistant professor of psychology at the University of New Mexico, and Sarah See Stith, assistant professor of economics at the same university, and published in the journal of Scientific Reports. . It revealed that THC exhibited the "strongest correlation with therapeutic relief, compared to the chemical found in the most socially acceptable cannabis, CBD (cannabinol)."
The cannabinoid content, and especially the THC content, proved to be the main factor in optimizing symptom relief when tested to treat a wide range of medical conditions. Dr. Vigil explained the results are based on the real-time information provided by the Releaf App. It was described by the doctor as "the largest database of its kind in our country." Using this app, patients reported the results and effects of their cannabis use and researchers compiled and processed this information.
Associated content material: Reasons why Ketamine use in therapy is now a thing
THC for Autism
While many cannabis researchers focus on CBD, a handful of them have been studying the medicinal benefits of its less medically popular cousin. THC, so adored by smokers, is often ignored by scientists. However, in recent years, it has sparked particular interest because of its potential to treat autism.
Erica Daniels is the founder of Autism Advisors and Hope Grows For Autism. She also appeared as a "cannamamá" in an episode of Weediquette de Viceland called "Mothers for Marijuana Treatment." He explained that in some people with autism, pure CBD can aggravate symptoms. Meanwhile, THC "tends to calm autistic patients during significant episodes of anxiety or crisis," he said.
After using THC-dominant products for her son for years, Erica reported that cannabis products containing THC improved her son's overall mood "by dramatically decreasing his anxiety and stress compared to CBD-only products."
Interestingly, the study conducted at the University of New Mexico seems to confirm this. In fact, he argues that cannabis turned out to be highly effective in treating severe (often mental) symptoms that are usually treated with benzodiazepines or antidepressants. Not so for severe symptoms that are typically palliated with opioids.
Associated Content material : What Is Hydroponic Marijuana and How to Grow It?
Filling the Void
According to Dr. Vigil, this study will help fill "the most significant absence in the preceding medical literature." The key is to understand "the efficacy, dosage, routes of administration or side effects of cannabis products normally used and available in the U.S. market."
In the name of education, Vigil recommends to curious readers a report on the effects of marijuana on health, published by the health committee of the U.S. National Academies of Science, Engineering and Medicine.
"Popular wisdom, both in the mass media and in much of the scientific community, points to the fact that only CBD has medicinal benefits while THC only places you. However, our results suggest that THC may be more important than CBD in generating therapeutic benefits," he said. In the study conducted by the University of New Mexico and Releaf App, CBD appeared to have little or no effect on most of the symptoms studied. By contrast, THC appeared to generate "measurable improvements in symptom relief."
Associated content material: CBD Products for Pets: A Financial Success!
In obtaining these results, Dr. Virgil called for the removal from the list of dangerous drugs without medicinal potential imposed by the DEA "all types of cannabis, in addition to hemp, so that cannabis with THC can be made more accessible for pharmaceutical use by the general public."
To conclude, Franco Brockelman, CEO of Releaf App, commented that "this study helps validate the medical importance of THC along with CBD, and the need for more conclusive research, to which we hope to contribute in the future."